Cocrystal Pharma to Participate in Two Investor Conferences in November
November 02 2022 - 8:00AM
Cocrystal Pharma, Inc. (Nasdaq: COCP) announces
that management will participate in two upcoming investor
conferences as follows:
- 2022 BioFlorida Annual
Conference: James Martin, CFO and interim co-CEO, will
participate in a panel titled “BioTrends: Learning from the
Pandemic: The Fight Against Infectious Diseases” on Thursday,
November 3 at 2:05 p.m. Eastern time. The conference is being held
at Hyatt Regency Miami. More information about the conference is
available here.
- Q4
Investor Summit: Mr. Martin will
present a company overview on Monday, November 14 at 11:30 a.m.
Eastern time. The conference is sponsored by the Investor Summit
Group and is being held at the Sheraton New York Time Square Hotel.
More information about the conference is available here.
A webcast of the Q4 Investor Summit presentation
will be posted to the IR Calendar page of the company website.
About Cocrystal Pharma,
Inc.Cocrystal Pharma, Inc. is a clinical-stage
biotechnology company discovering and developing novel antiviral
therapeutics that target the replication process of influenza
viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses
and noroviruses. Cocrystal employs unique structure-based
technologies and Nobel Prize-winning expertise to create first- and
best-in-class antiviral drugs. For further information about
Cocrystal, please visit www.cocrystalpharma.com.
Investor Contact:LHA Investor
RelationsJody Cain310-691-7100jcain@lhai.com
Media Contact:JQA PartnersJules
Abraham917-885-7378Jabraham@jqapartners.com
# # #
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Sep 2023 to Sep 2024